Xcellerex

🗓 Founded 2002👥 45 employees💰 Last funded Jan 2005
Pharmaceuticals🌐 xcellerex.com
Website LinkedIn
Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized. Xcellerex is built around a unique biomanufacturing platform that features the innovative application of single-use component technology. The Xcellerex platform transforms biomanufacturing economics by enabling: > Faster deployment of new manufacturing capacity: 12-18 months vs. 3-5 years. > Reduced capital investment: Typical savings of 50% to 70% compared to conventional approaches. > Unmatched flexibility: Modular microenvironment approach enables fast, low-cost redeployment for multi-drug production. Xcellerex offers a suite of world-class products and services to support the adoption of its platform. These include the XDR line of single-use bioreactors, PDMax® high-throughput process development and optimization services, and proven GMP manufacturing operated by an experienced CMC team. The company also actively seeks creative partnerships to facilitate access to the platform.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2002
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Xcellerex?
Xcellerex has 1 investors on record on gritt.io, 1 mid-stage.
When did Xcellerex last raise funding?
The most recent investment in Xcellerex recorded on gritt.io was in January 2005.
When was Xcellerex founded?
Xcellerex was founded in 2002.
What industry is Xcellerex in?
Xcellerex operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.